13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 36 holding rows worth $1,251,009,000.
- Accession
- 0001172661-20-001861
- Filer
- CIK 1281446
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 36 entries on the cover page, a total value of $1,251,009,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,251,009,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerKROIN DAVID028-13262
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 3,480,000 | $104,574,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 3,724,976 | $102,251,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 2,574,688 | $92,869,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 1,804,993 | $87,488,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 2,102,368 | $87,416,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 1,302,399 | $81,986,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 620,000 | $75,020,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 3,320,808 | $64,689,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 840,900 | $61,478,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 450,000 | $55,224,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 3,510,073 | $47,667,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 1,500,000 | $41,880,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,520,635 | $35,841,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 542,200 | $34,229,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 15,398,079 | $33,568,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 1,610,154 | $22,252,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 2,082,841 | $21,787,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 999,666 | $21,433,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 7,213,012 | $21,026,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 500,000 | $19,210,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 1,345,397 | $18,553,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 330,000 | $16,744,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 459,503 | $16,133,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 1,579,891 | $14,156,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 1,448,604 | $12,067,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 2,261,700 | $11,942,000 | thousands by filing date | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,277,955 | $10,760,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 203,500 | $6,825,000 | thousands by filing date | call |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 280,000 | $6,770,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 2,773,811 | $6,213,000 | thousands by filing date | |
| OYSTER POINT PHARMA INC | 69242L106 | COMMON STOCK | 214,631 | $6,199,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 58,056 | $5,531,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 675,679 | $3,459,000 | thousands by filing date | |
| MILLENDO THERAPEUTICS INC | 60040X103 | COM | 1,460,697 | $2,571,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 92,502 | $965,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 14,065 | $233,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-20-001861 | this filing | 2020-08-14 | acceptance time not in the bulk data set |